A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine
Abstract Yellow fever, a mosquito-borne flavivirus infection, is an important public health problem in Africa and Latin America. A Yellow Fever vaccine (YFV) was developed and tested in a study in India. This was a Phase I, open-label, randomized, controlled study where healthy adults received SII Y...
| Main Authors: | , , , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
Nature Portfolio
2022-12-01
|
| 叢編: | npj Vaccines |
| 在線閱讀: | https://doi.org/10.1038/s41541-022-00595-6 |